<DOC>
	<DOCNO>NCT00878124</DOCNO>
	<brief_summary>As woman age ovarian response pregnancy rate reduce rate chromosomal abnormality embryos increase . Oocyte maturation , accurate chromosomal segregation well early embryo development implantation dependent supply large amount energy , unlike cell arise mitochondrion . With age mitochondrion become less efficient due damage unique DNA , result decreased energy production . The propose study examine effect combination dietary supplement , Co enzyme Q10 pregnancy rate response ovaries medication stimulates follicle growth . The investigator hypothesize improve energetic state oocyte would result accurate chromosomal separation , increase embryo quality pregnancy rate .</brief_summary>
	<brief_title>How Dose Coenzyme Q10 Supplementation During Infertility Treatment Effects Pregnancy Outcome</brief_title>
	<detailed_description>The study organize outpatient basis Toronto Centre Advanced Reproductive Technology ( TCART ) Lifequest Centre Reproductive Medicine . The study involve 100 woman age 38-43 year . In first cycle , study participant randomly assign either placebo COQ10 capsule , ( AOR - Advanced Orthomolecular Research Inc. 19 St NE Calgary , Alberta , NHPD registration cod 135307 113519 , respectively ) . Study participant take 600 mg CoQ10 orally identical placebo capsule 5 cycle pregnancy occur . All subject commence control ovarian stimulation ( COH ) use highly purify human menopausal gonadotropin ( Menopur ; Ferring Inc. , North York , Ontario Canada ) . The starting dosage Menopur range 75IU 250 IU daily S.C. determine physician begin third day menses , continue day prior human chorionic gonadotropin ( hCG ) administration . The dosage change must maintain duration study . Menopur continue daily follicular development consider adequate . ( least 1 follicle &gt; 17 mm , E2 level acceptable number follicle present ) . The patient receive injection hCG 250 mcg ( Ovidrel , EMD Serono , Oakville , Ontario , Canada ) , SC final stage follicular maturation . Insemination intrauterine insemination ( IUI ) . Luteal support consist progesterone suppositiories 200mg ( Kingsway Pharmacy , Toronto , Ontario Canada ) vaginally per day start day IUI continue 2 week serum beta hCG result . At end cycle serum beta hCG draw woman pregnant CoQ10/ placebo discontinue . If pregnant , luteal support continue 10 week gestation . If patient pregnant cycle COH may attempt conceive naturally . In third cycle , COH use dose Menopur first cycle perform IUI cycle one . If pregnant , another cycle treatment follow fifth cycle COH IUI performed.. The study endpoint : 1 . Primary outcome measure pregnancy rate . 2 . Secondary outcome measure include : - Peak estradiol level - The number follicles &gt; 14 mm day hCG - Number day stimulation / unit Menopur need</detailed_description>
	<mesh_term>Coenzyme Q10</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<criteria>Each patient must meet following criterion : Age 3843 year time enrollment Diagnosis primary infertility Patients must NOT follow : Body mass index ( BMI ) &gt; 38 kg/m2 Early follicular phase ( day 24 ) serum FSH level &gt; 20 mIU/ml . Abnormal uterine cavity /or tubal blockage evidence sonohysterogram hysterosalpingography Any current use systemic steroid medication within 3 month study enrollment . Any contraindication pregnant carry pregnancy term . Contraindication use CoQ10 , Menopur , hCG , Prometrium . Any ovarian abdominal abnormality may interfere adequate TVS evaluation . Absence one ovary Clinically relevant systemic disease ( e.g. , Insulindependent diabetes , adrenal dysfunction , organic intracranial lesion , hyperprolactinemia , hypothalamic tumor ) serious illness ( Neoplasia ) . History ( within past 12 month ) current abuse alcohol drug . Administration investigational drug within three month prior study enrollment . Any medical condition may interfere absorption , distribution , metabolism excretion study drug , gastrointestinal disease , mal absorption syndrome liver dysfunction Unexplained gynecological bleeding . Abnormal sperm quality semen sample inadequate IUI preparation ( TMC &gt; 1x106 post wash ) Patient able communicate adequately investigator comply requirement entire study . Abnormal COH screen blood either partner , include : HIV serology , Hepatitis B C serology , Rubella , syphilis serology prior participation study . Unwillingness give write informed consent . The concurrent use follow drug : CoQ10 : Daunorubicin , Doxorubicin , Blood Pressure Medications , Warfarin , Timolol , atorvastatin , cerivastatin , lovastatin , pravastatin , simvastatin gemfibrozil , tricyclic antidepressant medication ( include amitriptyline , amoxapine , clomipramine , desipramine , doxepin , imipramine , nortriptyline , protriptyline , trimipramine ) .</criteria>
	<gender>Female</gender>
	<minimum_age>38 Years</minimum_age>
	<maximum_age>43 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Poor ovarian response</keyword>
	<keyword>Chromosomal aberration</keyword>
	<keyword>poor pregnancy outcome</keyword>
	<keyword>Late maternal age</keyword>
</DOC>